# Neujia Anastomosis for Treatment of Obesity and Type II Diabetes

> **NCT03675074** · NA · WITHDRAWN · sponsor: **Neurotronic, Inc.**

## Conditions studied

- Type2 Diabetes Mellitus
- Obesity

## Interventions

- **DEVICE:** Neujia

## Key facts

- **NCT ID:** NCT03675074
- **Lead sponsor:** Neurotronic, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-09-12
- **Primary completion:** 2018-12-04
- **Final completion:** 2019-01-21
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Deployment site not obtained in 5 patients with endoscopic screening and intent-to-treat. No devices implanted and no AEs through 30days.
- **Last updated:** 2019-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03675074

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03675074, "Neujia Anastomosis for Treatment of Obesity and Type II Diabetes". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03675074. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*